NEUREKA

NEUREKA

A smart, hybrid neural-silico-computo device for drug discovery

A visionary and innovative hybrid technology, whereby nanoelectrodes and sophisticated computational models of neuronal circuits are combined to readout and manipulate activity/connectivity in cultured neuronal networks of Alzheimer’s disease, with subcellular accuracy

An H2020 Future and Emerging Technology

The Concept

A radically-new science-enabled technology

People

NEUREKA is a partnership between 5 institutions

The Vision

Our long term vision is to revolutionize drug discovery for neurodegenerative diseases

NEUREKA PI Interview Series – Prof. Guilhem Larrieu

Welcome back to our series involving online interviews of the main Partners from the NEUREKA Consortium where they get the chance to tell us a little bit about their expertise as well as what they contribute towards this multinational multi-institutional project. This week we are interviewing Prof. Professor Gilham of LAAS/CNRS